GRAIL Inc.

GRAL Stock Healthcare Biotechnology
$79.79
+0.42 (+0.53%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+13.5%
3 Months
+33.2%
YTD
-6.8%
1 Year
+143.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
100.6%
Largest decline max drawdown, since Aug 2025
-62.9%
Risk-adjusted return Sharpe ratio, 1-year
1.45

Own GRAL?

See how GRAL contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.